Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch ...

TEL AVIV, Israel--(BUSINESS WIRE)--Sight Diagnostics Ⓡ, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today it has raised $71 million ...

Blood gas testing is often required for ventilator-assisted patients and those undergoing evaluation for respiratory distress, providing insights into a patient’s oxygenation level. The new RAPIDPoint ...

WASHINGTON, D.C., Oct. 3, 2017 -- About one quarter of the world's population suffers from anemia, a disease caused by a concentration deficiency of hemoglobin in red blood cells. To reduce the burden ...

Advances in controls and networks combined with components that pack more punch have opened the door to more-precise, durable, and economical pneumatic systems. Miniature CTS diaphragm pumps and ...

The only thing worse than getting a needle is getting two (or more) when the first jab attempt fails. Now, researchers from Rutgers and Mount Sinai Hospital have developed a robot that can see under ...

The opportunity presented in fingerprick blood testing is one that many companies are chasing. Among these is Israeli diagnostics firm Sight Diagnostics, which announced Wednesday that the Food and ...